Click for best price
Alzheimer's Treatment Drugs Market Size, Share 2023
This report contains market size and forecasts of Alzheimer's Treatment Drugs in Global, including the following market information:
Global Alzheimer's Treatment Drugs Market Revenue, 2018-2023, 2023-2032, ($ millions)
Global top five companies in 2022 (%)
The global Alzheimer's Treatment Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2032, at a CAGR of % during the forecast period 2023-2032.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2032.
Cholinesterase Inhibitors Segment to Reach $ Million by 2032, with a % CAGR in next six years.
The global key manufacturers of Alzheimer's Treatment Drugs include Eisai Co., Ltd., Novartis AG, Abbvie inc. (Allergan Plc), Adamas Pharmaceuticals, Inc., H. Lundbeck A/S, Biogen, AC Immune, DAIICHI SANKYO COMPANY, LIMITED and Johnson & Johnson Services Inc, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Alzheimer's Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alzheimer's Treatment Drugs Market, by Type, 2018-2023, 2023-2032 ($ millions)
Global Alzheimer's Treatment Drugs Market Segment Percentages, by Type, 2022 (%)
Cholinesterase Inhibitors
N-Methyl-D-Aspartate (NMDA) Receptor Antagonist
Combination Drug
Others
Global Alzheimer's Treatment Drugs Market, by Application, 2018-2023, 2023-2032 ($ millions)
Global Alzheimer's Treatment Drugs Market Segment Percentages, by Application, 2022 (%)
Online Sales
Offline Sales
Global Alzheimer's Treatment Drugs Market, By Region and Country, 2018-2023, 2023-2032 ($ Millions)
Global Alzheimer's Treatment Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alzheimer's Treatment Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Alzheimer's Treatment Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eisai Co., Ltd.
Novartis AG
Abbvie inc. (Allergan Plc)
Adamas Pharmaceuticals, Inc.
H. Lundbeck A/S
Biogen
AC Immune
DAIICHI SANKYO COMPANY, LIMITED
Johnson & Johnson Services Inc
TauRx Pharmaceuticals Ltd
F. Hoffmann La Roche Ltd.
| Report Attributes |
Report Details |
| Report Title |
Alzheimer's Treatment Drugs Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Alzheimer's Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Alzheimer's Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Alzheimer's Treatment Drugs Overall Market Size
2.1 Global Alzheimer's Treatment Drugs Market Size: 2022 VS 2032
2.2 Global Alzheimer's Treatment Drugs Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Alzheimer's Treatment Drugs Players in Global Market
3.2 Top Global Alzheimer's Treatment Drugs Companies Ranked by Revenue
3.3 Global Alzheimer's Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Alzheimer's Treatment Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Alzheimer's Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Alzheimer's Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Alzheimer's Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Alzheimer's Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Alzheimer's Treatment Drugs Market Size Markets, 2022 & 2032
4.1.2 Cholinesterase Inhibitors
4.1.3 N-Methyl-D-Aspartate (NMDA) Receptor Antagonist
4.1.4 Combination Drug
4.1.5 Others
4.2 By Type - Global Alzheimer's Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Alzheimer's Treatment Drugs Revenue, 2018-2023
4.2.2 By Type - Global Alzheimer's Treatment Drugs Revenue, 2023-2032
4.2.3 By Type - Global Alzheimer's Treatment Drugs Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Alzheimer's Treatment Drugs Market Size, 2022 & 2032
5.1.2 Online Sales
5.1.3 Offline Sales
5.2 By Application - Global Alzheimer's Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Alzheimer's Treatment Drugs Revenue, 2018-2023
5.2.2 By Application - Global Alzheimer's Treatment Drugs Revenue, 2023-2032
5.2.3 By Application - Global Alzheimer's Treatment Drugs Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Alzheimer's Treatment Drugs Market Size, 2022 & 2032
6.2 By Region - Global Alzheimer's Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Alzheimer's Treatment Drugs Revenue, 2018-2023
6.2.2 By Region - Global Alzheimer's Treatment Drugs Revenue, 2023-2032
6.2.3 By Region - Global Alzheimer's Treatment Drugs Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Alzheimer's Treatment Drugs Revenue, 2018-2032
6.3.2 US Alzheimer's Treatment Drugs Market Size, 2018-2032
6.3.3 Canada Alzheimer's Treatment Drugs Market Size, 2018-2032
6.3.4 Mexico Alzheimer's Treatment Drugs Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Alzheimer's Treatment Drugs Revenue, 2018-2032
6.4.2 Germany Alzheimer's Treatment Drugs Market Size, 2018-2032
6.4.3 France Alzheimer's Treatment Drugs Market Size, 2018-2032
6.4.4 U.K. Alzheimer's Treatment Drugs Market Size, 2018-2032
6.4.5 Italy Alzheimer's Treatment Drugs Market Size, 2018-2032
6.4.6 Russia Alzheimer's Treatment Drugs Market Size, 2018-2032
6.4.7 Nordic Countries Alzheimer's Treatment Drugs Market Size, 2018-2032
6.4.8 Benelux Alzheimer's Treatment Drugs Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Alzheimer's Treatment Drugs Revenue, 2018-2032
6.5.2 China Alzheimer's Treatment Drugs Market Size, 2018-2032
6.5.3 Japan Alzheimer's Treatment Drugs Market Size, 2018-2032
6.5.4 South Korea Alzheimer's Treatment Drugs Market Size, 2018-2032
6.5.5 Southeast Asia Alzheimer's Treatment Drugs Market Size, 2018-2032
6.5.6 India Alzheimer's Treatment Drugs Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Alzheimer's Treatment Drugs Revenue, 2018-2032
6.6.2 Brazil Alzheimer's Treatment Drugs Market Size, 2018-2032
6.6.3 Argentina Alzheimer's Treatment Drugs Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Alzheimer's Treatment Drugs Revenue, 2018-2032
6.7.2 Turkey Alzheimer's Treatment Drugs Market Size, 2018-2032
6.7.3 Israel Alzheimer's Treatment Drugs Market Size, 2018-2032
6.7.4 Saudi Arabia Alzheimer's Treatment Drugs Market Size, 2018-2032
6.7.5 UAE Alzheimer's Treatment Drugs Market Size, 2018-2032
7 Players Profiles
7.1 Eisai Co., Ltd.
7.1.1 Eisai Co., Ltd. Corporate Summary
7.1.2 Eisai Co., Ltd. Business Overview
7.1.3 Eisai Co., Ltd. Alzheimer's Treatment Drugs Major Product Offerings
7.1.4 Eisai Co., Ltd. Alzheimer's Treatment Drugs Revenue in Global Market (2018-2023)
7.1.5 Eisai Co., Ltd. Key News
7.2 Novartis AG
7.2.1 Novartis AG Corporate Summary
7.2.2 Novartis AG Business Overview
7.2.3 Novartis AG Alzheimer's Treatment Drugs Major Product Offerings
7.2.4 Novartis AG Alzheimer's Treatment Drugs Revenue in Global Market (2018-2023)
7.2.5 Novartis AG Key News
7.3 Abbvie inc. (Allergan Plc)
7.3.1 Abbvie inc. (Allergan Plc) Corporate Summary
7.3.2 Abbvie inc. (Allergan Plc) Business Overview
7.3.3 Abbvie inc. (Allergan Plc) Alzheimer's Treatment Drugs Major Product Offerings
7.3.4 Abbvie inc. (Allergan Plc) Alzheimer's Treatment Drugs Revenue in Global Market (2018-2023)
7.3.5 Abbvie inc. (Allergan Plc) Key News
7.4 Adamas Pharmaceuticals, Inc.
7.4.1 Adamas Pharmaceuticals, Inc. Corporate Summary
7.4.2 Adamas Pharmaceuticals, Inc. Business Overview
7.4.3 Adamas Pharmaceuticals, Inc. Alzheimer's Treatment Drugs Major Product Offerings
7.4.4 Adamas Pharmaceuticals, Inc. Alzheimer's Treatment Drugs Revenue in Global Market (2018-2023)
7.4.5 Adamas Pharmaceuticals, Inc. Key News
7.5 H. Lundbeck A/S
7.5.1 H. Lundbeck A/S Corporate Summary
7.5.2 H. Lundbeck A/S Business Overview
7.5.3 H. Lundbeck A/S Alzheimer's Treatment Drugs Major Product Offerings
7.5.4 H. Lundbeck A/S Alzheimer's Treatment Drugs Revenue in Global Market (2018-2023)
7.5.5 H. Lundbeck A/S Key News
7.6 Biogen
7.6.1 Biogen Corporate Summary
7.6.2 Biogen Business Overview
7.6.3 Biogen Alzheimer's Treatment Drugs Major Product Offerings
7.6.4 Biogen Alzheimer's Treatment Drugs Revenue in Global Market (2018-2023)
7.6.5 Biogen Key News
7.7 AC Immune
7.7.1 AC Immune Corporate Summary
7.7.2 AC Immune Business Overview
7.7.3 AC Immune Alzheimer's Treatment Drugs Major Product Offerings
7.7.4 AC Immune Alzheimer's Treatment Drugs Revenue in Global Market (2018-2023)
7.7.5 AC Immune Key News
7.8 DAIICHI SANKYO COMPANY, LIMITED
7.8.1 DAIICHI SANKYO COMPANY, LIMITED Corporate Summary
7.8.2 DAIICHI SANKYO COMPANY, LIMITED Business Overview
7.8.3 DAIICHI SANKYO COMPANY, LIMITED Alzheimer's Treatment Drugs Major Product Offerings
7.8.4 DAIICHI SANKYO COMPANY, LIMITED Alzheimer's Treatment Drugs Revenue in Global Market (2018-2023)
7.8.5 DAIICHI SANKYO COMPANY, LIMITED Key News
7.9 Johnson & Johnson Services Inc
7.9.1 Johnson & Johnson Services Inc Corporate Summary
7.9.2 Johnson & Johnson Services Inc Business Overview
7.9.3 Johnson & Johnson Services Inc Alzheimer's Treatment Drugs Major Product Offerings
7.9.4 Johnson & Johnson Services Inc Alzheimer's Treatment Drugs Revenue in Global Market (2018-2023)
7.9.5 Johnson & Johnson Services Inc Key News
7.10 TauRx Pharmaceuticals Ltd
7.10.1 TauRx Pharmaceuticals Ltd Corporate Summary
7.10.2 TauRx Pharmaceuticals Ltd Business Overview
7.10.3 TauRx Pharmaceuticals Ltd Alzheimer's Treatment Drugs Major Product Offerings
7.10.4 TauRx Pharmaceuticals Ltd Alzheimer's Treatment Drugs Revenue in Global Market (2018-2023)
7.10.5 TauRx Pharmaceuticals Ltd Key News
7.11 F. Hoffmann La Roche Ltd.
7.11.1 F. Hoffmann La Roche Ltd. Corporate Summary
7.11.2 F. Hoffmann La Roche Ltd. Business Overview
7.11.3 F. Hoffmann La Roche Ltd. Alzheimer's Treatment Drugs Major Product Offerings
7.11.4 F. Hoffmann La Roche Ltd. Alzheimer's Treatment Drugs Revenue in Global Market (2018-2023)
7.11.5 F. Hoffmann La Roche Ltd. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Alzheimer's Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Alzheimer's Treatment Drugs Market Drivers in Global Market
Table 3. Alzheimer's Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Alzheimer's Treatment Drugs in Global Market
Table 5. Top Alzheimer's Treatment Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Alzheimer's Treatment Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Alzheimer's Treatment Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Alzheimer's Treatment Drugs Product Type
Table 9. List of Global Tier 1 Alzheimer's Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alzheimer's Treatment Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Alzheimer's Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Alzheimer's Treatment Drugs Revenue in Global (US$, Mn), 2023-2032
Table 14. By Application ? Global Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Alzheimer's Treatment Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Alzheimer's Treatment Drugs Revenue in Global (US$, Mn), 2023-2032
Table 17. By Region ? Global Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Alzheimer's Treatment Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Alzheimer's Treatment Drugs Revenue (US$, Mn), 2023-2032
Table 20. By Country - North America Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2023-2032
Table 22. By Country - Europe Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2023-2032
Table 24. By Region - Asia Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2023-2032
Table 26. By Country - South America Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2023-2032
Table 28. By Country - Middle East & Africa Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2023-2032
Table 30. Eisai Co., Ltd. Corporate Summary
Table 31. Eisai Co., Ltd. Alzheimer's Treatment Drugs Product Offerings
Table 32. Eisai Co., Ltd. Alzheimer's Treatment Drugs Revenue (US$, Mn), (2018-2023)
Table 33. Novartis AG Corporate Summary
Table 34. Novartis AG Alzheimer's Treatment Drugs Product Offerings
Table 35. Novartis AG Alzheimer's Treatment Drugs Revenue (US$, Mn), (2018-2023)
Table 36. Abbvie inc. (Allergan Plc) Corporate Summary
Table 37. Abbvie inc. (Allergan Plc) Alzheimer's Treatment Drugs Product Offerings
Table 38. Abbvie inc. (Allergan Plc) Alzheimer's Treatment Drugs Revenue (US$, Mn), (2018-2023)
Table 39. Adamas Pharmaceuticals, Inc. Corporate Summary
Table 40. Adamas Pharmaceuticals, Inc. Alzheimer's Treatment Drugs Product Offerings
Table 41. Adamas Pharmaceuticals, Inc. Alzheimer's Treatment Drugs Revenue (US$, Mn), (2018-2023)
Table 42. H. Lundbeck A/S Corporate Summary
Table 43. H. Lundbeck A/S Alzheimer's Treatment Drugs Product Offerings
Table 44. H. Lundbeck A/S Alzheimer's Treatment Drugs Revenue (US$, Mn), (2018-2023)
Table 45. Biogen Corporate Summary
Table 46. Biogen Alzheimer's Treatment Drugs Product Offerings
Table 47. Biogen Alzheimer's Treatment Drugs Revenue (US$, Mn), (2018-2023)
Table 48. AC Immune Corporate Summary
Table 49. AC Immune Alzheimer's Treatment Drugs Product Offerings
Table 50. AC Immune Alzheimer's Treatment Drugs Revenue (US$, Mn), (2018-2023)
Table 51. DAIICHI SANKYO COMPANY, LIMITED Corporate Summary
Table 52. DAIICHI SANKYO COMPANY, LIMITED Alzheimer's Treatment Drugs Product Offerings
Table 53. DAIICHI SANKYO COMPANY, LIMITED Alzheimer's Treatment Drugs Revenue (US$, Mn), (2018-2023)
Table 54. Johnson & Johnson Services Inc Corporate Summary
Table 55. Johnson & Johnson Services Inc Alzheimer's Treatment Drugs Product Offerings
Table 56. Johnson & Johnson Services Inc Alzheimer's Treatment Drugs Revenue (US$, Mn), (2018-2023)
Table 57. TauRx Pharmaceuticals Ltd Corporate Summary
Table 58. TauRx Pharmaceuticals Ltd Alzheimer's Treatment Drugs Product Offerings
Table 59. TauRx Pharmaceuticals Ltd Alzheimer's Treatment Drugs Revenue (US$, Mn), (2018-2023)
Table 60. F. Hoffmann La Roche Ltd. Corporate Summary
Table 61. F. Hoffmann La Roche Ltd. Alzheimer's Treatment Drugs Product Offerings
Table 62. F. Hoffmann La Roche Ltd. Alzheimer's Treatment Drugs Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Alzheimer's Treatment Drugs Segment by Type in 2022
Figure 2. Alzheimer's Treatment Drugs Segment by Application in 2022
Figure 3. Global Alzheimer's Treatment Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Alzheimer's Treatment Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Alzheimer's Treatment Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Alzheimer's Treatment Drugs Revenue in 2022
Figure 8. By Type - Global Alzheimer's Treatment Drugs Revenue Market Share, 2018-2032
Figure 9. By Application - Global Alzheimer's Treatment Drugs Revenue Market Share, 2018-2032
Figure 10. By Region - Global Alzheimer's Treatment Drugs Revenue Market Share, 2018-2032
Figure 11. By Country - North America Alzheimer's Treatment Drugs Revenue Market Share, 2018-2032
Figure 12. US Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2032
Figure 13. Canada Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2032
Figure 14. Mexico Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2032
Figure 15. By Country - Europe Alzheimer's Treatment Drugs Revenue Market Share, 2018-2032
Figure 16. Germany Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2032
Figure 17. France Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2032
Figure 18. U.K. Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2032
Figure 19. Italy Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2032
Figure 20. Russia Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2032
Figure 21. Nordic Countries Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2032
Figure 22. Benelux Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2032
Figure 23. By Region - Asia Alzheimer's Treatment Drugs Revenue Market Share, 2018-2032
Figure 24. China Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Japan Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. South Korea Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2032
Figure 27. Southeast Asia Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2032
Figure 28. India Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. By Country - South America Alzheimer's Treatment Drugs Revenue Market Share, 2018-2032
Figure 30. Brazil Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Argentina Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. By Country - Middle East & Africa Alzheimer's Treatment Drugs Revenue Market Share, 2018-2032
Figure 33. Turkey Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2032
Figure 34. Israel Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. Saudi Arabia Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2032
Figure 36. UAE Alzheimer's Treatment Drugs Revenue, (US$, Mn), 2018-2032
Figure 37. Eisai Co., Ltd. Alzheimer's Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Novartis AG Alzheimer's Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. Abbvie inc. (Allergan Plc) Alzheimer's Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Adamas Pharmaceuticals, Inc. Alzheimer's Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. H. Lundbeck A/S Alzheimer's Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Biogen Alzheimer's Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. AC Immune Alzheimer's Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. DAIICHI SANKYO COMPANY, LIMITED Alzheimer's Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson & Johnson Services Inc Alzheimer's Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. TauRx Pharmaceuticals Ltd Alzheimer's Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. F. Hoffmann La Roche Ltd. Alzheimer's Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
